Maggi Leonard B, Weber Jason D
Department of Medicine, Division of Molecular Oncology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Cancer Invest. 2005;23(7):599-608. doi: 10.1080/07357900500283085.
While the nucleolus was first observed over two hundred years ago, its role in human cancers is only now being appreciated. Long thought to be a static, ribosome-producing, subnuclear organelle, recent investigations have shown a more dynamic and adaptable side of the nucleolus. Containing not only proteins for the production of ribosomes but also newfound nucleolar oncogenes and tumor suppressors, mechanistic links between the nucleolus and cancer are now more evident. In this regard, much of the work from the past decade has focused on the ability of these proteins to promote and suppress tumorigenesis from the nucleolus. In this review, we will discuss how historical measurements of the nucleolus are being translated into contemporary studies of nucleolar dysfunction in human cancer.
虽然核仁在两百多年前就首次被观察到,但其在人类癌症中的作用直到现在才被认识到。长期以来,人们一直认为核仁是一个静态的、产生核糖体的亚核细胞器,但最近的研究揭示了核仁更具动态性和适应性的一面。核仁不仅含有用于核糖体生产的蛋白质,还含有新发现的核仁癌基因和肿瘤抑制因子,核仁与癌症之间的机制联系现在更加明显。在这方面,过去十年的许多工作都集中在这些蛋白质从核仁促进和抑制肿瘤发生的能力上。在这篇综述中,我们将讨论核仁的历史测量方法是如何转化为对人类癌症中核仁功能障碍的当代研究的。